FDA Inspection 1252455 — Cayce C. Tangeman, M.D.
The FDA completed an inspection of Cayce C. Tangeman, M.D. on Oct 18, 2024 in North Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- North Charleston, SC (United States)
Additional details
Clinical Investigator (CI)